» Download Public Reports
About 100 reports
- Industry report
- March 2012
- 5 pages
... Label products: the exclusive pharmacy products from the field of diagnostics are now also available in germany. With the high-quality and at the same time high-earnings medical devices, pharmacies can ...
February 2012
... Successful strategy used in influencing the biosynthetic pathways to activate and increase the production of secon-dary metabolites is by feeding cell cultures with precursors (smetanska, 2008). Precursors ...
February 2012
... To the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range ...
February 2012
... To further develop employees beyond work-related training - roche diagnostics bears the cost for rooms, material, trainers etc. - Seminars take place outside of regular working times roche diagnostics ...
February 2012
... biological imaging n orma lize d by re sp on se s in % . Cost models for external access to imaging facilities biological and medical imaging in biological imaging, 40% of users clearly prefer ...
January 2012
... Copyright dr. Michael friebe medical imaging innovation medical imaging entrepreneurship -- medical imaging market -- dr. Michael friebe Product / service needs to have benefits over existing products ...
January 2012
... Equipment in hospitals is discussed in terms of cost and profitability below. As the cost reduction in hospitals is a major objective, we conducted a cost ana- lysis of two anaesthetic machines, the Primus ...
» Purchase Premium Reports
(From $ 100 - $ 23 520)
About 800 reports
- $ 29 400
- Industry report
- March 2012
- by Venture Planning Group
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances ...
April 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
February 2012
$ 28 700
Complete report $28,700.  . This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...
March 2012
$ 28 500
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
March 2012
$ 28 500
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and ...
April 2012
$ 28 400
This report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The report explores ...